An open-label phase I study to evaluate the safety, tolerability and preliminary efficacy of YY001 in patients with advanced solid tumors

被引：0
|
作者：
Xue, Liqiong
Tang, Wenbo
Zhou, Huan
Liu, Mulin
Liu, Yuanyuan
Wang, Jinhua
Chen, Jianfeng
Liu, Mingyao
Guo, Ye
机构：
[1] Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai, Peoples R China
[2] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
[3] Bengbu Med Univ, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Shanghai Yuyao Biotech Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15104
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics, Safety, and Preliminary Efficacy of Oral Trifluridine/Tipiracil in Chinese Patients with Solid Tumors: A Phase 1b, Open-Label Study
    Wang, Xicheng
    Zhou, Jianfeng
    Li, Yan
    Ge, Yuping
    Zhou, Yanping
    Bai, Chunmei
    Shen, Lin
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2020, 12 : 21 - 33
  • [42] Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors
    Sang, Y. B.
    Kim, Y.
    Lee, M. A.
    Rha, S. Y.
    Jung, M.
    Lee, C-K.
    Park, Y. H.
    Heo, D.
    Kim, A.
    Kim, J.
    Kim, J-H.
    ANNALS OF ONCOLOGY, 2023, 34 : S474 - S474
  • [43] Phase I study to assess the safety, tolerability, pharmacokinetics/pharmacodynamics and preliminary efficacy of SC10914 in patients with advanced solid tumors.
    Gong, Jifang
    Tang, Jinhai
    Yin, Yongmei
    Ye, Dingwei
    Zhang, Jian
    Zheng, Hong
    Gao, Yunong
    Jang, Haoyuan
    Chen, Xiao
    Zhang, Zhe
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] An open-label, non-randomized, multi-center phase I study evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of bi-ligand-drug conjugate CBP-1018 in patients with advanced solid tumors
    Li, Kaiwen
    Shi, Yehui
    Wu, Junyan
    Zhou, Liyan
    Ye, Suiwen
    Lai, Xiuping
    Huang, Robert
    Teng, Yan
    Yu, Jiangang
    Chai, Xiaoyan
    Huang, Hai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] An open-label, MRCT phase I/II study evaluating the safety, tolerability, pharmacokinetics and preliminary efficacy of first-in-class bi-ligand-drug conjugate CBP-1019 in patients (pts) with advanced solid tumors
    Liu, D.
    Shen, L.
    Sun, Y.
    Li, N.
    Marathe, O.
    Huang, R.
    Shao, J.
    Xu, M.
    Pan, B.
    Pan, F.
    Gao, S.
    Gong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S512 - S513
  • [46] An Open-Label Extension Study to Evaluate Safety and Efficacy of Pazopanib in Patients with Advanced Renal Cell Carcinoma
    Sternberg, Cora N.
    Davis, Ian D.
    Deen, Keith C.
    Sigal, Entisar
    Hawkins, Robert E.
    ONCOLOGY, 2014, 87 (06) : 342 - 350
  • [47] Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study
    Sherman, E.
    Lee, J. L.
    Debruyne, P. R.
    Keam, B.
    Shin, S. J.
    Gramza, A.
    Caro, I.
    Amin, R.
    Shah, K.
    Yan, Y.
    Huddart, R.
    Powles, T.
    ESMO OPEN, 2023, 8 (02)
  • [48] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Saif, Muhammad Wasif
    Becerra, Carlos R.
    Fakih, Marwan G.
    Sun, Weijing
    Popovic, Lazar
    Krishnamurthi, Smitha
    George, Thomas J.
    Rudek, Michelle A.
    Shepard, Dale R.
    Skopek, Jiri
    Sramek, Vladimir
    Zaric, Bojan
    Yamamiya, Ikuo
    Benhadji, Karim A.
    Hamada, Kensuke
    He, Yaohua
    Rosen, Lee
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (03) : 485 - 497
  • [49] An Open-Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia
    Fox, Susan H.
    Swan, Matthew
    Jinnah, Hyder A.
    Freitas, Maria E. T.
    Oliveira, Lais M.
    Al-Shorafat, Duha
    Fernandez, Hubert H.
    Kompoliti, Katie
    Comella, Cynthia
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (05): : 743 - 749
  • [50] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Muhammad Wasif Saif
    Carlos R. Becerra
    Marwan G. Fakih
    Weijing Sun
    Lazar Popovic
    Smitha Krishnamurthi
    Thomas J. George
    Michelle A. Rudek
    Dale R. Shepard
    Jiri Skopek
    Vladimir Sramek
    Bojan Zaric
    Ikuo Yamamiya
    Karim A. Benhadji
    Kensuke Hamada
    Yaohua He
    Lee Rosen
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 485 - 497
12345